Home-based Mobile Guided Exercise-based Cardiac Rehabilitation Among Patients Undergoing TAVR
REHAB-TAVR
A Home-based Mobile Guided Exercise-based Cardiac Rehabilitation Among Patients Undergoing Transcatheter Aortic Valve Replacement (REHAB-TAVR): a Randomized Clinical Trial
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
A two-parallel, evaluator-blind, single-center, randomized controlled trial was designed to assess the effectiveness of a home-based mobile guided exercise-based cardiac rehabilitation among patients undergoing Transcatheter Aortic Valve Replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedAugust 14, 2023
August 1, 2023
7 months
August 3, 2023
August 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in 6-minute Walk Distance
Distance walked in 6 minutes
Month 3
Secondary Outcomes (3)
Change in 6-minute Walk Distance
Month 6
Change in Short Physical Performance Battery (SPPB)
Month 3 and Month 6
Exercise Adherence Assessed by the Exercise Adherence Rating Scale (EARS)
Month1, Month 3 and Month 6
Other Outcomes (27)
All-cause Rehospitalizations and death
Month 3 and Month 6
Handgrip Strength
Month 3 and Month 6
Frailty Status Assessed by the Fried Frailty Criteria
Month 3 and Month 6
- +24 more other outcomes
Study Arms (2)
The REHAB-TAVR group
ACTIVE COMPARATORFor the REHAB-TAVR group, discharge preparation will involve an exercise endurance test, exercise prescription guidance, motivational interviews, instruction on telerehabilitation, and the provision of family and peer support. Following discharge, patients will be required to adhere to their personalized exercise prescription and attend scheduled onsite follow-ups after discharge. The management model employed for this group is called home-based mobile guided exercise-based cardiac rehabilitation.
The Routine-TAVR group
OTHERPreparation for discharge will only involve an exercise endurance test and the guidance of an exercise prescription for the Routine-TAVR group. Following discharge, nurses will conduct monthly telephone follow-ups to check on the patient's progress. Additionally, patients will be scheduled for onsite follow-ups at the Outpatient Department.
Interventions
Discharge preparation, telerehabilitation, scheduled onsite follow-ups, telephone follow-ups, self-reporting, health education, online communication, family and peer support, mailing letters, institutional referrals, and security management.
Discharge preparation, scheduled onsite follow-ups, telephone follow-ups
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years and ≤ 89 years old;
- Patients scheduled to be discharged after TAVR;
- Those who have the ability to read and write, and have normal speech and communication skills;
- Patients and their families are willing to participate in this study;
- Patients or family members have the ability to use mobile and an app.
You may not qualify if:
- Serious complications occur before discharge (such as major bleeding, stroke, valve detachment, moderate or above perivalve leakage, coronary artery occlusion, etc.) ;
- Patients who are unable to participate in postoperative exercise rehabilitation due to limb dysfunction;
- Being in palliative care or treatment;
- Those with other Contraindication to exercise-based cardiac rehabilitation (such as resting ECG changes indicating significant ischemia, acute myocardial infarction or other acute cardiac events, unstable angina, uncontrolled arrhythmia, heart failure decompensation, etc.);
- Currently participating in other rehabilitation projects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Newman-Beinart NA, Norton S, Dowling D, Gavriloff D, Vari C, Weinman JA, Godfrey EL. The development and initial psychometric evaluation of a measure assessing adherence to prescribed exercise: the Exercise Adherence Rating Scale (EARS). Physiotherapy. 2017 Jun;103(2):180-185. doi: 10.1016/j.physio.2016.11.001. Epub 2016 Nov 9.
PMID: 27913064BACKGROUNDNagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, Shinohara K, Yokoyama T, Eguchi A, Ogusu A, Ikeda M, Ishikawa Y, Yamashita F, Kinugawa S, Tsutsui H. Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty. ESC Heart Fail. 2022 Aug;9(4):2407-2418. doi: 10.1002/ehf2.13934. Epub 2022 May 9.
PMID: 35534907RESULTShen Z, Mi S, Huang C, Zhou D, Pan W, Xu X, Lin Y, Zhang Y. Home-based mobile-guided exercise-based cardiac rehabilitation among patients undergoing transcatheter aortic valve replacement (REHAB-TAVR): protocol for a randomised clinical trial. BMJ Open. 2024 Mar 7;14(3):e080042. doi: 10.1136/bmjopen-2023-080042.
PMID: 38453208DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Zhiyun Shen
Fudan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2023
First Posted
August 14, 2023
Study Start
September 1, 2023
Primary Completion
March 31, 2024
Study Completion
June 30, 2024
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share